Track the Dawnrays Pharmaceutical (Holdings) Ltd. stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Dawnrays Pharmaceutical (Holdings) Ltd. has recorded 21 reports. Market capitalisation: €1.5bn. The latest transaction was reported on 7 September 2026 (Purchase). Among the most active insiders: Hung Yung Lai. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
€121,881
20 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Buys €121,881n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 820 of 29,062 companies
82.3
score / 100
Value
93
Quality
72
FCF yld16%
Earn yld14%
EV/EBITDA4.3x
ROE6.9%
Gross mgn50%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
84,000 shares@ HK$1.090.0060% mcap29.2% of flowShareXHKGHKEX:DA20260331E00415
21 of 21 declarations
Acerca de Dawnrays Pharmaceutical (Holdings) Ltd.
Dawnrays Pharmaceutical (Holdings) Ltd. es una empresa centrada en el desarrollo y la fabricación de productos farmacéuticos. Cotiza en la Bolsa de Hong Kong (XHKG).